20
Participants
Start Date
May 31, 2014
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2018
Endopath from Itamar medical - FDA approved device.
endothelial function assessment by Endopath device
Anti TNF Alfa.
This study will assessed the presence of endothelial dysfunction in patients with Crohn's disease before and after 12 weeks treatment of anti TNF α.
RECRUITING
Carmel Medical Center, Haifa
Lead Sponsor
Carmel Medical Center
OTHER